Aligning sample size calculations with estimands in clinical trials with time-to-event outcomes

被引:0
作者
Fang, Yixin [1 ]
Jin, Man [1 ]
Wu, Chengqing [2 ]
机构
[1] Fang 1 North Waukegan Rd, N Chicago, IL 60064 USA
[2] 55,Challenger Rd STE 501, Ridgefield Pk, NJ 07660 USA
关键词
AND PHRASES; Clinical trials; Estimand; current events; Sample size; Time-to-event;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The ICH E9(R1) guidance recommended a framework to align planning, design, conduct, analysis, and interpretation of any clincial trial with its objective and estimand. How to handle intercurrent events (ICEs) is one of the five attributes of an estimand and sample size calculation is a key step in the trial planning and design. Therefore, sample size calcula-tion should be aligned with the estimand and, in particular, with how the ICEs are handled. ICH E9(R1) summarized five strategies for handling ICEs, and five approaches have been proposed in the literature for sample size calculation when planning trials with quantitative and binary outcomes. In this paper, we discuss how to apply the five strategies to deal with ICEs in clinical trials with time-to-event outcomes and propose five approaches for sample size calculation that are aligned with the five strategies, respectively. AMS 2000 SUBJECT CLASSIFICATIONS: Primary 62N03, 62G10; secondary 62G99.
引用
收藏
页码:63 / 68
页数:6
相关论文
共 13 条
  • [1] Introduction to the Analysis of Survival Data in the Presence of Competing Risks
    Austin, Peter C.
    Lee, Douglas S.
    Fine, Jason P.
    [J]. CIRCULATION, 2016, 133 (06) : 601 - 609
  • [2] ANALYSIS OF LONGITUDINAL TRIALS WITH PROTOCOL DEVIATION: A FRAMEWORK FOR RELEVANT, ACCESSIBLE ASSUMPTIONS, AND INFERENCE VIA MULTIPLE IMPUTATION
    Carpenter, James R.
    Roger, James H.
    Kenward, Michael G.
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2013, 23 (06) : 1352 - 1371
  • [3] CHOW S.-C., 2017, Sample size calculations in clinical research
  • [4] Efficient Multiple Imputation for Sensitivity Analysis of Recurrent Events Data With Informative Censoring
    Diao, Guoqing
    Liu, Guanghan F.
    Zeng, Donglin
    Zhang, Yilong
    Golm, Gregory
    Heyse, Joseph F.
    Ibrahim, Joseph G.
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2022, 14 (02): : 153 - 161
  • [5] Sample Size Calculation When Planning Clinical Trials with Intercurrent Events
    Fang, Yixin
    Jin, Man
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (04) : 779 - 785
  • [6] Principal stratification in causal inference
    Frangakis, CE
    Rubin, DB
    [J]. BIOMETRICS, 2002, 58 (01) : 21 - 29
  • [7] ICH E9(R1), 2020, ICH E9(R1) addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials
  • [8] Imbens GW, 2015, CAUSAL INFERENCE FOR STATISTICS, SOCIAL, AND BIOMEDICAL SCIENCES: AN INTRODUCTION, P1, DOI 10.1017/CBO9781139025751
  • [9] Julious S.A., 2009, Sample sizes for clinical trials, V1st
  • [10] KALBFLEISCH J. D., 2011, The statistical analysis of failure time data, V360